Page last updated: 2024-12-08

bradykinin, (thi-ala)(5,8)-phe(7)-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bradykinin, (Thi-Ala)(5,8)-Phe(7)-: antagonist of bradykinin at the B2 receptor; RN refers to (L)-Pro isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID163661
MeSH IDM0151366

Synonyms (8)

Synonym
npc 431
(2s)-2-[[(2s)-2-[[(2r)-2-[[(2s)-2-[[(2s)-2-[[2-[[(2s)-1-[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoy
5,8-(thi-ala)-7-phe-bradykinin
ta5,8-f7-bk
bradykinin, (thi-ala)(5,8)-phe(7)-
(thi(5,8),d-phe(7))bradykinin
bradykinin, thienylalanyl(5,8)-phenylalanine(7)-
bradykinin, 5-(3-(2-thienyl)-l-alanine)-7-d-phenylalanine-8-(3-(2-thienyl)-l-alanine)-

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In alpha-chloralose-anesthetized rats, tachyphylaxis to pericardial administration of 1 microgram BK occurred at 5 and 15, but not at 30 min dosing intervals."( Use of an indwelling catheter for examining cardiovascular responses to pericardial administration of bradykinin in rat.
Gebhart, GF; Gutterman, DD; McDermott, DA; Meller, ST, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's4 (57.14)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.21 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]